Massive U.S. Government Delegation Seeks Common Ground In China To Counter Threats To Peace And Health
BEIJING - One of the most extensive American government delegations to make a state visit to China - headed by Secretary of State Hillary Clinton and Treasury Secretary Tim Geithner - posted only sporadic progress this week across a spectrum of issues affecting ties between the globe's financially hobbled superpower and fastest rising economic force, yet the two sides renewed an important pact on jointly tracking and fighting infectious diseases that have the potential to crisscross the continents
More from Archive
Optimizing Drug Pipelines With Biophysical Methods”, your view into how using biophysical techniques can enhance and streamline processes throughout the drug discovery and validation cycle.
- • By
CEO Paul Stoffels said gaining US clearance for an IND for its novel CAR-T product was demanding, but now opens up a pathway towards a pivotal study starting in 2025.
- • By
A final rejection of Leqembi could also spell the same fate for Lilly’s rival drug but public outcry and demand for Alzheimer’s therapies might force the regulator’s hand
- • By
GSK will assume full control of mRNA shots in infectious disease, allowing CureVac to cut costs and pivot its research to oncology.
More from Scrip
- Sponsored by :
As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.
Lilly's first Phase III triplet win opens the door to a label expansion in BTK-pretreated CLL, with analysts suggesting Jaypica could attain blockbuster status. However, the window to capitalize may be brief as next-generation BTK degraders close in with head-to-head trials.






